Search

Displaying results 5781 - 5790 of 8196 in total
  1. Drug

    Xininurad

    go.drugbank.com/drugs/DB21564
    Experimental

    Xininurad has a monoisotopic molecular weight of 440.91 Da.

  2. Drug

    Ansornitinib

    go.drugbank.com/drugs/DB21577
    Experimental

    Ansornitinib has a monoisotopic molecular weight of 540.25 Da.

  3. Drug

    Garsorasib

    go.drugbank.com/drugs/DB21581
    Investigational

    Garsorasib has a monoisotopic molecular weight of 598.26 Da.

  4. Drug

    Gumelutamide

    go.drugbank.com/drugs/DB21615
    Experimental

    Gumelutamide has a monoisotopic molecular weight of 420.15 Da.

  5. Drug

    Frevecitinib

    go.drugbank.com/drugs/DB21681
    Investigational

    Frevecitinib has a monoisotopic molecular weight of 415.18 Da.

  6. Drug

    Odentegravir

    go.drugbank.com/drugs/DB21708
    Experimental

    Odentegravir has a monoisotopic molecular weight of 421.12 Da.

  7. Drug

    Afabicin

    go.drugbank.com/drugs/DB15268
    Investigational

    Afabicin is under investigation in clinical trial NCT03723551 (Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus

  8. Drug

    RAPA-501-Allo

    go.drugbank.com/drugs/DB15890
    Investigational

    RAPA-501-ALLO is composed of T-cells extracted from healthy volunteers; these cells are then reprogrammed _ex vivo_ in a process that involves de-differentiation and re-differentiation.[L16483]

  9. Drug

    Chymotrypsin

    go.drugbank.com/drugs/DB09375
    ApprovedInvestigationalVet approvedWithdrawn

    Chymotrypsin (EC 3.4.21.1) is a digestive enzyme that promotes proteolysis, or the breakdown of proteins and polypeptides. It is a serine protease synthesized in the pancreas and is a vital component in the pancreatic juice. Like most pr...

  10. Drug

    PHE885

    go.drugbank.com/drugs/DB18123
    Investigational

    PHE885 is an investigational, autologous B-cell Maturation Antigen (BCMA)-directed chimeric antigen receptor (CAR)-T cell therapy.